DAPAGLIFLOZIN (Forxiga®)
Clinical Indication
Chronic Heart failure with reduced ejection fraction and preserved ejection fraction
Comments
In line with NICE TA679 and NICE TA902
Date of classification
March 2021
Yellow
Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .